and the part I really liked was "Even if the drug is priced conservatively, Ardelyx appears to be an easy potential multi-bagger of several magnitudes if investors can hold on to it for a decade."

So they are just going to see if they can prescribe their current IBS drug to kids, awesome!

$ARDX IBS drug total rx (TRX)are steady and growing.

$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.

$ARDX Most drugs do not peak until 5 years from launch and we are at 1m $ / week after 41 weeks!

Dilution to launch TWO global drugs is money well spent.

They just got approval for 1 drug from FDA and things are bot going well there..

Now we're getting all these new drugs that really work well."

$ARDX come on you this other drug going off and this one is way better what the hell is everybody thinking let’s goooooo

The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network.

Two (2) other drugs, each growing revenue steadily.

#Novavax — a protein-based #vaccine which has been remanufactured by the Serum Institute of India and is still awaiting the drug regulatory body’s approval for roll-out — performed better than other vaccines available in India.

PLus we have an ongoing pipeline of very promising drugs.

Unique MoA that has multiple potential indications, can literally be life changing, and is an altruistic drug to support.

They have much more valuable cancer drugs in the works, more innovated cutting edge companies where people are going to invest.

Best drug in pharma history and criminal shorts.

This company is absolute value and their first product is approved world wide.

We declare doctors should not be blocked from providing life-saving medical treatment. 3.

We know the drug is unreal and beats the hell out of vanc in every metric.

Still the best cdiff drug ever.

Drug pipe for $ACXP makes me optimistic.

Ridinilazole is a good drug and I suspect Duggan will find a market for it.

If Ibezapolstat shows 95% cure and 5% recurrence then we could have a drug on our hands that is an economic and humanitarian godsend, obviating all other therapies existence at $10K per dose for 500000 cases per year.

This is why the bile acid profile is perfectly restored after 3 days and competing drugs either had very small improvements in bile acid ratio (ridin), or complete destruction (vanc).

Exciting to watch this wonder drug go from the laboratory to the clinic, and beyond.

This drug works and there is a lot of data that suggests this will be better than vancomycin and at least as good as fidaxomicin. https://seekingalpha.com/article/4522940-seres-therapeutics-the-good-and-challenging

A+ drug deserves the A-team.